Target intelligence / Profile preview

ST18 antisense RNA 3 (ST18-AS3)

Target
ST18-AS3
Molecular classification
Long non-coding RNA, Antisense RNA
01

Overview

ST18 antisense RNA 3 (ST18-AS3) likely refers to a putative non-coding RNA transcribed from the DNA strand opposite the ST18 protein-coding gene. Antisense RNAs are typically involved in the regulation of gene expression, often by hybridizing with the sense (mRNA) transcript to affect its stability or translation. However, as of this review, there is no substantive characterization of ST18-AS3 in the literature, and no established function, disease association, or druggability. Most research pertains to the ST18 protein, a zinc finger transcription factor involved in regulating apoptosis and inflammation. Thus, ST18-AS3 is not presently recognized as a therapeutic target. Key points: - The entry may be incorrect or excessively speculative as a molecular target. - There is no robust evidence for its function, disease roles, or druggability. - Remove or replace with "ST18" (the transcription factor) if a protein-coding target is intended.

Other names
ST18-AS3ST18 antisense RNA 3
02

Mechanism of action

Not established; general mechanism for antisense RNAs includes hybridization to complementary mRNA to inhibit translation or modulate stability.

03

Biological functions

Regulation of ST18 gene expression (inferred from general antisense RNA principles, not from direct evidence for ST18-AS3)
04

Disease associations

Other (possible, not confirmed): No direct disease association is established for ST18-AS3. The ST18 protein itself is implicated in cancer, apoptosis, and inflammation, but this is not documented for the antisense RNA itself.

Beyond the preview

Go deeper on ST18 antisense RNA 3 (ST18-AS3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ST18 antisense RNA 3 (ST18-AS3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call